top of page
30abbf_80cbda8aa51445e28421bf1c4f0491a5~mv2.jpg

Expertise

VIA Performance
eConsent Performance
73%
18%
9%
55%
18%
9%
9%
9%
18%
18%
9%
18%
37%
57%
43%
14%
14%
15%
43%
43%
14%
14%
15%
2024.03 Now
By Country
By Phase
By Therapeutic Area
By Country
By Phase
By Therapeutic Area
KOR
EU
JPN
Phase II
Phase III
OS/PMS
Medical Device
ETC.
Ophthalmology
Gastroenterology
Cardiovasular
Neurology
ETC.
KOR
JPN
IIT
Phase I
Phase III
Food & supplementary
Ophthalmology
Neurology
ETC.
Immunology
14%
14%
OS/PMS
Cardiovascular
Partnerships

Spero's business partners range from local and overseas clinical trial sponsors, pharmaceutical and medical device companies, to CROs and clinical research sites and centers

Key fields of cooperation

  • Clinical development operation (CRO service)
  • Patient recruitment service support
  • DCT solution operation support
Ophthanlmology
Gastroenterology
Endocrinology
Cardiovascular
Neurology
Others
15%
15%
15%
5%
15%
35%
Achievement

Spero started patient recruitment service in 2021 and has been accumulating achievements in various CRO service areas since it expanded its business to DCT in 2022.

Therapeutic Area & Phase

Experienced Staffs and Potential expertise

Spero is enhancing its expertise and operational efficiency for the successful execution of clinical trials

By Therapeutic area
By Phase
Others
Medical Device
IIT
OS
PMS
Phase IV
Phase I
Phase III
Phase II
5%
5%
15%
10%
50%
15%

Spero supports all phases of clinical trials, and prioritizes customer requirements, and the safety of clinical trials

Full Support Service

Clinical Operation
12%
18%
27%
33%
6%
3%
Statistics
Data Management
Medical Writing
Site Management
Project Management
Site Startup
By Operation service
bottom of page